Overexpression of IL-6 in experimental animals subjected to viral myocarditis results in extensive myocardial inflammation, whereas IL-6 inhibition with tocilizumab reduced heart inflammation and infiltration with CD3+T-cells and CD68+ macrophages (20). The gene discussed is IL6; the disease is inflammation.